It has been observed that the metabolic effects of pharmacological activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) on glucose intolerance and fatty acid oxidation were mediated by GDF15 expression [19]. Here, GDF15 is linked to Glucose intolerance.